LIfT Biosciences

LIfT is the only biotech company in the world with a Neutrophil Based Cell Therapy Platform (N-LIfT). 
The N-LIfT platform is flexible & unique which enables us to produce different types of Immuno-Modulatory Alpha Neutrophils (IMANs) for a wide range of different purposes. Different IMANs can be developed to treat cancers, auto-immune diseases, neurological conditions and anti-microbial resistance. 

The company is working with a range of pharmaceutical license partners to develop a portfolio of CAR-IMAN cell therapies to deliver complete remission across all solid tumours before the decade is out. LIfT BioSciences was founded by Alex Blyth.